TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11099761

Group type: EXPERIMENTAL
Intervention: Executed actions with varying target force (low, moderate) and rate of force development (slow, rapid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagined actions with varying target force (low, moderate) and rate of force development (slow, rapid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Executed actions at SMA/PMA with varying target force (low, moderate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Executed actions at FCz with varying rate of force development (rapid, slow)
Number of subjects: 0
Study: 8805928

Group type: EXPERIMENTAL
Intervention: Cisplatin in combination with teniposide and vincristine
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Carboplatin in combination with teniposide and vincristine
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with teniposide plus cisplatin or carboplatin
Number of subjects: 484

Group type: COMPARATOR
Intervention: Alternating treatment with block A, B and C (arm III)
Number of subjects: 484
Study: 1458770

Group type: EXPERIMENTAL
Intervention: Isoproterenol (0.1, 0.2, 0.4, 0.75, and 1.5 micrograms/min for 15 minutes)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline control infusion
Number of subjects: 10
Study: 6385890

Group type: EXPERIMENTAL
Intervention: Propranolol (60 mg every 6 hours)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31613885

Group type: EXPERIMENTAL
Intervention: Structured model for integrated OA care (SAMBA model) facilitated by workshops and physiotherapist-led education and exercise programme for 8-12 weeks.
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Structured model for integrated OA care (SAMBA model)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 393
Study: 29051047

Group type: EXPERIMENTAL
Intervention: Ostomy Self-management Training (OSMT) program delivered via telehealth; includes four group sessions and an additional session for caregivers.
Number of subjects: 0
Study: 27015578

Group type: EXPERIMENTAL
Intervention: LMAP (target MAP of 50 mm Hg)
Number of subjects: 168

Group type: COMPARATOR
Intervention: HMAP (target MAP of 65 mm Hg)
Number of subjects: 168
Study: 24662864

Group type: EXPERIMENTAL
Intervention: HSA plus high FFP/RBC resuscitation (Group D)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Balanced electrolyte solution (BES) plus low FFP/RBC resuscitation (Group A)
Number of subjects: 94
Study: 23087138

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BNP) 0.000025 g x kg(‐2) administered by patient‐controlled intravenous analgesia (PCIA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Morphine 0.00075 g x kg(‐2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Morphine 0.0011 g x kg(‐2)
Number of subjects: 120
Study: 21053703

Group type: EXPERIMENTAL
Intervention: Nicotine replacement and cessation counseling
Number of subjects: 755

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 755
Study: 18843002

Group type: EXPERIMENTAL
Intervention: BR-DIM 100 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: BR-DIM 200 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: BR-DIM 300 mg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 16086621

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 328
Study: 12036805

Group type: EXPERIMENTAL
Intervention: Sterol-free corn oil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Corn oil with 150 mg phytosterols
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Corn oil with 300 mg phytosterols
Number of subjects: 10

Group type: COMPARATOR
Intervention: Commercial corn oil
Number of subjects: 10
Study: 9461319

Group type: EXPERIMENTAL
Intervention: Leptin concentrations in lean women (BMI <25 kg/m2)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Leptin concentrations in lean men (BMI <25 kg/m2)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Leptin concentrations in moderately overweight and obese individuals (BMI 25-30 kg/m2 and BMI >30 kg/m2)
Number of subjects: 415
Study: 8569975

Group type: EXPERIMENTAL
Intervention: 1 alpha-hydroxyvitamin D3 derivatives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral administration of alkaline salts of calcium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dialysate calcium concentrations (1.25-1.00 mmol/l)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonhypercalcemic hyperphosphatemic vitamin D3 derivatives in combination with oral calcium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D derivatives
Number of subjects: 0
Study: 1697390

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of nisoldipine and propranolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 14
Study: 100331

Group type: EXPERIMENTAL
Intervention: Fibroblast interferon preparations for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 31881599

Group type: EXPERIMENTAL
Intervention: AeroForm device
Number of subjects: 50
Study: 31793472

Group type: EXPERIMENTAL
Intervention: Turkish Music Perception Test (MPT)
Number of subjects: 100
Study: 28383400

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily (except on dialysis days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard non-RAAS antihypertensive agents
Number of subjects: 100
Study: 25489763

Group type: EXPERIMENTAL
Intervention: Left double-lumen tracheal tubes without a hook
Number of subjects: 184

Group type: COMPARATOR
Intervention: Left double-lumen tracheal tubes with a hook
Number of subjects: 184
Study: 24078335

Group type: EXPERIMENTAL
Intervention: Daily hemodialysis (DHD)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Conventional hemodialysis (C)
Number of subjects: 245
Study: 22492936

Group type: EXPERIMENTAL
Intervention: Impulsive acceleration stimulus applied to the mastoid
Number of subjects: 13

Group type: COMPARATOR
Intervention: Galvanic stimulation (GVS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: 500-Hz vibration
Number of subjects: 13

Group type: COMPARATOR
Intervention: Seated position during stimulation
Number of subjects: 13
Study: 19204301

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 10101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10101
Study: 17276267

Group type: EXPERIMENTAL
Intervention: Hydrophilic acrylic IOL with haptic angulation (ACR6D SE, Laboratoires Cornéal)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Hydrophilic acrylic IOL without haptic angulation (C-flex 570C, Rayner)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Comparison of both IOL groups
Number of subjects: 52
Study: 15045504

Group type: EXPERIMENTAL
Intervention: Running sprints
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cycling sprints
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Repeated sprints
Number of subjects: 25
Study: 12654211

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 26
Study: 9034263

Group type: EXPERIMENTAL
Intervention: Gentamicin (loading dose administered)
Number of subjects: 322
Study: 8094392

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX; 8 mg, orally)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (PRO; 40 mg, orally) after DEX
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clonidine (CLO; 0.300 mg, orally) after DEX
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PD; 120 mg, orally) after DEX
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (PRO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clonidine (CLO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PD)
Number of subjects: 10
Study: 3298088

Group type: EXPERIMENTAL
Intervention: Liquid carbohydrate-rich feeding (L)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Solid carbohydrate-rich feeding (S)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ad libitum solid food consumption (AL)
Number of subjects: 8
Study: 30295914

Group type: EXPERIMENTAL
Intervention: Session-introducing intervention with mindfulness elements (SIIME)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 162
Study: 28791787

Group type: EXPERIMENTAL
Intervention: 5:2 diet (two non-consecutive days of 2460 KJ (600 calories) and 5 days of ad libitum eating per week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard energy-restricted diet (SERD) (2050 KJ (500 calorie) reduction per day)
Number of subjects: 24
Study: 27317044

Group type: EXPERIMENTAL
Intervention: Brief advice and referral to external AOD services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 25293480

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no BIS monitoring)
Number of subjects: 60
Study: 22832260

Group type: EXPERIMENTAL
Intervention: Bivalent rLP2086 vaccine (60, 120, or 200 μg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bivalent rLP2086 vaccine
Number of subjects: 48
Study: 20226843

Group type: EXPERIMENTAL
Intervention: Physical stress (high intensity exercise, 12 min, 70-85% HR max, n=19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cognitive stress (Letter Digit Span and d2-test, n=21)
Number of subjects: 40
Study: 18065368

Group type: EXPERIMENTAL
Intervention: Intralesional steroid
Number of subjects: 24

Group type: COMPARATOR
Intervention: Silicone gel sheeting
Number of subjects: 24
Study: 16094554

Group type: EXPERIMENTAL
Intervention: Rehabilitation program (duration: 6 months)
Number of subjects: 117
Study: 12948311

Group type: EXPERIMENTAL
Intervention: 0.5% piroxicam ophthalmic solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.1% diclofenac sodium ophthalmic solution
Number of subjects: 40
Study: 10982578

Group type: EXPERIMENTAL
Intervention: Eclipse
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nicotrol inhaler
Number of subjects: 50
Study: 8831918

Group type: EXPERIMENTAL
Intervention: 100 mg ciprofibrate/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 200 mg ciprofibrate/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 200 mg fenofibrate HB/day
Number of subjects: 18
Study: 1403397

Group type: EXPERIMENTAL
Intervention: Dexamethasone, 0.25 mg/kg per dose, every 8 hours for a total of three doses
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 50
Study: 4059871

Group type: EXPERIMENTAL
Intervention: Tobramycin injections every 8 hours (TID) for 4 days followed by every 12 hours (BID)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Tobramycin injections every 12 hours (BID) for 4 days followed by every 8 hours (TID)
Number of subjects: 11
Study: 2979067

Group type: EXPERIMENTAL
Intervention: Morphine sulfate, 5 to 10 mg IV
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meperidine, 25 to 50 mg IV
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Shivering (graded 0 to 4)
Number of subjects: 30
Study: 30866981

Group type: EXPERIMENTAL
Intervention: Comprehensive team‐based intervention including practice facilitation, workflow mapping, practice improvement model, education for patients, and community partnership for social marketing campaign
Number of subjects: 40
Study: 27888575

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (2 g infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 60
Study: 25500574

Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (0.3 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rectal diazepam (0.5 mg/kg)
Number of subjects: 100
Study: 23040523

Group type: EXPERIMENTAL
Intervention: hCG (0 IU, 15 IU, 60 IU, or 125 IU) SC every other day
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 7.5 g T gel daily (75 mg delivered)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: GnRH antagonist acyline
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (0 IU hCG)
Number of subjects: 37
Study: 21455729

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) with up to five individual counselling sessions in 1 year, in addition to usual care
Number of subjects: 349

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 349
Study: 19087606

Group type: EXPERIMENTAL
Intervention: Yunnan Baiyao capsules (prophylactic oral administration for 3 days before operation)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control (no Yunnan Baiyao administration)
Number of subjects: 87
Study: 16491236

Group type: EXPERIMENTAL
Intervention: Fibroblasts from primary pterygia
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fibroblasts from recurrent pterygia
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fibroblasts from normal Tenon capsule
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fleshy and involutive pterygia
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pterygia of Grades I‐II and III‐IV
Number of subjects: 43
Study: 15312097

Group type: EXPERIMENTAL
Intervention: Plaque control program
Number of subjects: 555

Group type: COMPARATOR
Intervention: Control group (discontinued after 6 years)
Number of subjects: 555
Study: 10686207

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided embryo transfer
Number of subjects: 362

Group type: COMPARATOR
Intervention: Clinical touch embryo transfer
Number of subjects: 362
Study: 9356856

Group type: EXPERIMENTAL
Intervention: Bionormalizer (BN) 9g by mouth every night for one week
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 8469324

Group type: EXPERIMENTAL
Intervention: Felbamate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 3511933

Group type: EXPERIMENTAL
Intervention: Phenobarbitone (50 mg for 10 days)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Flumecinol (200 mg and 600 mg for 6 days)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cimetidine (600 mg for 6 days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 29377186

Group type: EXPERIMENTAL
Intervention: Reminders of the stereotype about women's communality
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Reminders of the stereotype about men's agency
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control/no-stereotype condition
Number of subjects: 202
Study: 27439969

Group type: EXPERIMENTAL
Intervention: Distal colonic acetate infusion (180 mmol/l)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Distal colonic acetate infusion (100 mmol/l)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Proximal colonic acetate infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 6
Study: 24893832

Group type: EXPERIMENTAL
Intervention: Lacosamide 100mg/day for 4.5 days
Number of subjects: 35
Study: 23672224

Group type: EXPERIMENTAL
Intervention: Western drugs
Number of subjects: 9061

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine
Number of subjects: 9061

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 9061
Study: 20518763

Group type: EXPERIMENTAL
Intervention: TURis‐PVP
Number of subjects: 155

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 155
Study: 18271842

Group type: EXPERIMENTAL
Intervention: Online mid-dilution hemodiafiltration (HDF-MD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-flux hemodialysis (HF-HD)
Number of subjects: 8
Study: 15693603

Group type: EXPERIMENTAL
Intervention: Mandibular overdenture on two implants (IMP-group)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Conventional complete dentures (VP-group)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Complete denture after preprosthetic surgery (MVP-group)
Number of subjects: 149
Study: 30220293

Group type: EXPERIMENTAL
Intervention: Newly developed generic formulation of abiraterone acetate (250 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Branded formulation of abiraterone acetate (Zytiga, 250 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Food intake
Number of subjects: 80
Study: 10518263

Group type: EXPERIMENTAL
Intervention: Free smoke alarms and fire safety information distributed by community groups and paid workers.
Number of subjects: 160000
Study: 7675718

Group type: EXPERIMENTAL
Intervention: Long arm plaster immobilization
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Short arm plaster immobilization
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ace Wrap bandage
Number of subjects: 31
Study: 2405727

Group type: EXPERIMENTAL
Intervention: Meglumine antimonate (Glucantime), 850 mg antimony/day im for 15 days
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Localized controlled heat, 50 degrees C for 30 sec, 3 treatments at 7 day intervals
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 6990946

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam every six hours for 48 hours
Number of subjects: 131

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 131
Study: 28799030

Group type: EXPERIMENTAL
Intervention: Video instruction (VI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: External focus (EF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 40
Study: 26476086

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (SBP <120 mm Hg)
Number of subjects: 3087

Group type: COMPARATOR
Intervention: Standard blood pressure lowering (SBP <140 mm Hg)
Number of subjects: 3087

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 3087
Study: 24872892

Group type: EXPERIMENTAL
Intervention: 12-month multicomponent obesity prevention intervention
Number of subjects: 1474

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1474
Study: 22742578

Group type: EXPERIMENTAL
Intervention: Paracetamol 4000 mg q.d.s.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg q.d.s.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Paracetamol 4000 mg q.d.s. and Aspirin 325 mg q.d.s.
Number of subjects: 60
Study: 20378868

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate infusion
Number of subjects: 327

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 327
Study: 17356283

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for comorbid anxiety disorder
Number of subjects: 34

Group type: COMPARATOR
Intervention: Alcohol treatment alone
Number of subjects: 34
Study: 16323384

Group type: EXPERIMENTAL
Intervention: TENS over the acupuncture points plus infrared irradiation
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Exercise training plus infrared irradiation
Number of subjects: 218

Group type: COMPARATOR
Intervention: Infrared irradiation alone
Number of subjects: 218
Study: 12510991

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9832573

Group type: EXPERIMENTAL
Intervention: Handled infants (n = 21)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nonhandled infants (n = 27)
Number of subjects: 48
Study: 7865625

Group type: EXPERIMENTAL
Intervention: Anti-tumour-associated glycoprotein 72 antibody B72.3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-specific murine immunoglobulins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat extraction of serum samples
Number of subjects: 0
Study: 2724027

Group type: EXPERIMENTAL
Intervention: MCC containing paste
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo paste
Number of subjects: 36
Study: 29659438

Group type: EXPERIMENTAL
Intervention: Interscalene block (ISB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Suprascapular-axillary nerve block (SSB)
Number of subjects: 100
Study: 27829410

Group type: EXPERIMENTAL
Intervention: Active catgut implantation at acupoints (two sessions, once every two weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham catgut implantation at acupoints (two sessions, once every two weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active catgut implantation at acupoints
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham catgut implantation at acupoints
Number of subjects: 0
Study: 24829088

Group type: EXPERIMENTAL
Intervention: 150 ml glucose drink (200 kcal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glucose infusion at 4 kcal/min into the proximal Roux-limb
Number of subjects: 10

Group type: COMPARATOR
Intervention: 4 kcal/min duodenal infusion (control group)
Number of subjects: 10
Study: 22689678

Group type: EXPERIMENTAL
Intervention: Post‐consolidation immunotherapy with histamine dihydrochloride and interleukin‐2
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Histamine dihydrochloride
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Histamine H(2) receptor expression
Number of subjects: 145
Study: 20300027

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study: 18853933

Group type: EXPERIMENTAL
Intervention: Gaboxadol 15 mg (GBX15)
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Gaboxadol 10 mg (GBX10)
Number of subjects: 794

Group type: EXPERIMENTAL
Intervention: Gaboxadol 5 mg (GBX5)
Number of subjects: 794

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 794
Study: 16087995

Group type: EXPERIMENTAL
Intervention: 8 g/d of a mixed short and long degree of polymerization inulin-type fructan product (fructan group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maltodextrin placebo (control group)
Number of subjects: 0
Study: 12454760

Group type: EXPERIMENTAL
Intervention: epoetin alfa
Number of subjects: 375

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 375